LTFS
VIVO

Ladenburg Thalmann Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$16K Sell
1,574
-3,589
-70% -$33.7K ﹤0.01% 4269
2019
Q3 		$49K Buy
5,163
+294
+6% +$3.1K ﹤0.01% 3476
2019
Q2 		$58K Buy
4,869
+2,591
+114% +$31.2K ﹤0.01% 3362
2019
Q1 		$40K Buy
2,278
+1,187
+109% +$19.7K ﹤0.01% 3564
2018
Q4 		$19K Hold
1,091
– – ﹤0.01% 3912
2018
Q3 		$16K Hold
1,091
– – ﹤0.01% 4052
2018
Q2 		$16K Hold
1,091
– – ﹤0.01% 3979
2018
Q1 		$16K Hold
1,091
– – ﹤0.01% 3979
2017
Q4 		$16K Hold
1,091
– – ﹤0.01% 3937
2017
Q3 		$16K Hold
1,091
– – ﹤0.01% 3822
2017
Q2 		$17K Sell
1,091
-933
-46% -$13.4K ﹤0.01% 3716
2017
Q1 		$28K Sell
2,024
-241
-11% -$3.37K ﹤0.01% 3331
2016
Q4 		$40K Hold
2,265
– – ﹤0.01% 3020
2016
Q3 		$43K Buy
2,265
+84
+4% +$1.64K ﹤0.01% 2899
2016
Q2 		$42K Buy
2,181
+42
+2% +$824 ﹤0.01% 2817
2016
Q1 		$46K Buy
2,139
+536
+33% +$10.6K ﹤0.01% 2662
2015
Q4 		$33K Hold
1,603
– – ﹤0.01% 2882
2015
Q3 		$26K Hold
1,603
– – ﹤0.01% 2943
2015
Q2 		$31K Buy
1,603
+81
+5% +$1.5K ﹤0.01% 2937
2015
Q1 		$29K Buy
1,522
+122
+9% +$2.26K ﹤0.01% 2953
2014
Q4 		$23K Sell
1,400
-1,600
-53% -$27.4K ﹤0.01% 2906
2014
Q3 		$53K Sell
3,000
-495
-14% -$9.72K ﹤0.01% 2000
2014
Q2 		$72K Sell
3,495
-585
-14% -$12K ﹤0.01% 1811
2014
Q1 		$89K Buy
4,080
+162
+4% +$3.71K ﹤0.01% 1578
2013
Q4 		$104K Sell
3,918
-10
-0.3% -$246 ﹤0.01% 1462
2013
Q3 		$93K Buy
3,928
+53
+1% +$1.24K ﹤0.01% 1440
2013
Q2 		$83K Buy
+3,875
New +$83.6K ﹤0.01% 1415

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VIVO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Meridian Bioscience Inc (VIVO) stake by 70% in Q4 2019, selling an estimated $33.7K and leaving 1,574 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #4269.

Ladenburg Thalmann Financial Services first reported a position in VIVO in Q2 2013 and has held it in 27 quarters since. The position peaked at $104K in Q4 2013. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,574 shares of Meridian Bioscience Inc worth $16K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 3,589 Meridian Bioscience Inc shares in Q4 2019, an estimated $33.7K.
  • Meridian Bioscience Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4269 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Meridian Bioscience Inc position peaked at $104K in Q4 2013.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.